| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_280464e04fb8da1ea3d8ed20d3b2ba39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02bdedcecbba428d05d106adf07c3825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ddc5a94d222be39ac8e62320c439790
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84e1d51e1b2f1feb4a97dc92aebc7a76 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-81 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-683 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 |
| filingDate |
1995-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bff32196c54fba25295b2b0fd2a2be23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfcf20cac50ff6f6f458f6f4e700aae1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7dcd25d8869687aaf1cda827ed7f104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b269a699baa325b2b51a60ac970ed49 |
| publicationDate |
1996-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9618336-A2 |
| titleOfInvention |
Marker for individuals susceptible to alcoholism |
| abstract |
The present invention relates to methods for diagnosis of susceptibility to alcoholism or the pathological effects of alcoholism based on detection of a genetic marker in an individual. The present invention is directed generally to methods and associated compositions and kits for detecting the presence of arylsulfatase A (ASA) pseudodeficiency (PD) mutations in humans. Detection of these mutations has been surprisingly found to be a strong indicator for susceptibility to alcoholism and/or susceptibility to alcohol's pathological effects, as well as an important marker in evaluating the likelihood of metachromatic leukodystrophy (MLD). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9805796-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5935790-A |
| priorityDate |
1994-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |